Read Full Article
“We are thrilled to welcome Ed to our board of directors ,” said Jonathan P. Mow, Chief Executive Officer of PhaseBio. “We will benefit greatly from Ed's ...
We are thrilled to welcome Ed to our board of directors.
PhaseBio is rapidly progressing product candidates through the clinic and building a portfolio of important medicines to address orphan disease areas of high unmet medical need.